Loading
ROBO Medical
ROBO Medical (Shenzhen ROBO Medical Technology Co., Ltd.) researches and builds medical robots. Its products include parallel-mechanism surgical robots such as a digestive endoscopy surgery robot, tele-ultrasound and assistant robots for remote diagnosis, a disinfection robot and lower-limb rehabilitation devices. It sells to hospitals and works with Chinese hospitals and the China Telemedicine Association. Revenue comes from product sales plus after-sale service, customer training and service hosting. The company was founded in 2015 (some sources say 2013) and began in Switzerland and Silicon Valley before moving its HQ to Shenzhen. PitchBook lists funding rounds in 2017 and 2018 (about $2.95M raised by 2018), then Series A in 2023, Series A2 in 2024 and Series B in July 2025. Crunchbase lists Fenglei Capital and Tailong Investment among its investors, and headcount is about 51–100.
Funding
Every round, secondary, debt facility or acquisition involving ROBO Medical that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—